United States · FDA National Drug Code directory
Ledipasvir and Sofosbuvir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72626-2601_bd8387fe-8338-4241-b084-aec76726f8a9
- Product NDC
- 72626-2601
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ledipasvir and Sofosbuvir
- Labeler
- Asegua Therapeutics LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20190101
- Source listing expiry
- 20261231
Source-listed ingredients
- LEDIPASVIR — 90 mg/1
- SOFOSBUVIR — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (72626-2601-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK · 72626-2601-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →